Vanessa K. Burrows is an associate in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Washington, D.C., office. She focuses her practice on health care law, with an emphasis on medical device, food and drug, and pharmacy law. Her broad-based experience also includes HIPAA compliance, health privacy and security laws, and public health law. She advises health care entities and their contractors on compliance, regulatory, data-sharing, licensing, and enforcement matters.
Previously, Vanessa served as the HIPAA Privacy Officer for the City of Chicago and an attorney for the Chicago Department of Public Health. In that capacity, she advised the City’s covered entities and business associates, as well as the health department’s executive team. She provided guidance on emergency preparedness authorities and public health laws on communicable diseases, HIV/AIDS/STIs, scope of practice, mental health, tobacco, and quarantine and isolation.
Prior to joining the City of Chicago, Vanessa worked on Capitol Hill as a Legislative Attorney for the Congressional Research Service in Washington, DC, where she advised Members of Congress and their staff in the areas of health law, administrative law, and constitutional law. She addressed specific legal issues in legislation including the Patient Protection and Affordable Care Act (ACA), the Food and Drug Administration Safety and Innovation Act (FDASIA), the Family Smoking Prevention and Tobacco Control Act (TCA), and the Food and Drug Administration Amendments Act (FDAAA).
More Legal and Business Bylines From Vanessa K. Burrows
- 21st Century Cures: Examining Provisions for Streamlining FDA Regulations for Clinical Research in Title III - (Posted On Thursday, December 15, 2016)
- Government Issues New Tool to Help Mobile App Developers Identify Applicable Federal Laws - (Posted On Wednesday, April 20, 2016)
- FDA Delays Enforcement of Restaurant Menu Labeling Rule - (Posted On Monday, March 14, 2016)
- Ohio Court of Appeals Upholds a Successor Manufacturer’s Termination of a Distribution Franchise - (Posted On Thursday, March 03, 2016)
- FDA Aims to Expand Sentinel Capabilities, Include Evaluation of Drug Effectiveness - (Posted On Wednesday, February 17, 2016)
- FDA Releases Draft Guidance on Postmarket Management of Cybersecurity in Medical Devices - (Posted On Wednesday, January 27, 2016)
- New HIPAA Privacy Rule Permits Disclosures to Background Check System - (Posted On Wednesday, January 13, 2016)
- FDA Releases Guidance on Voluntary Labeling for Foods Derived from Genetically Engineered Plants - (Posted On Monday, November 30, 2015)
- FDA Seeks Input on Uses of “Natural” in Food and Beverage Labeling - (Posted On Wednesday, November 25, 2015)
- FDA Issues Revised Draft Guidance on Disclosures of Risk Information in Consumer-Friendly Print Advertisements and Promotional Labeling - (Posted On Thursday, March 19, 2015)